Heart Disease Clinical Trials in Utah

92 recruiting studies across 14 cities

All Trials in Utah

Phase
Trial Phase Location
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3American Fork
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Bountiful
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Clearfield
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPhase 2Clinton
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationPhase 3Clinton
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Phase 3Layton
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsPhase 3Layton
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Layton
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry—Lehi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Murray
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial FibrillationN/AMurray
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial FibrillationPhase 2Murray
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High RiskPhase 3Murray
AMEND TS Early Feasibility StudyN/AMurray
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/AMurray
Abbott Cephea Mitral Valve Disease Registry—Murray
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Murray
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease—Murray
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve DysfunctionN/AMurray
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/AMurray
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/AMurray
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Murray
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Murray
Medtronic Terminate AF StudyN/AMurray
PARTNER 3 Trial - Aortic Valve-in-ValveN/AMurray
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/AMurray
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction IIN/AMurray
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Murray
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).N/AMurray
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency DepartmentN/AMurray
: Vascular Function in Health and DiseasePhase 1Salt Lake City
A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury—Salt Lake City
A Phase 2 Study of CRD-4730 in CPVTPhase 2Salt Lake City
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD StudyN/ASalt Lake City
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment—Salt Lake City
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsPhase 3Salt Lake City
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Salt Lake City
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Salt Lake City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Salt Lake City
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 2Salt Lake City
ATrial Tachycardia PAcing Therapy in Congenital Heart—Salt Lake City
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3Salt Lake City
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3Salt Lake City
An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisPhase 2Salt Lake City
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Salt Lake City
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Salt Lake City
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart DiseaseN/ASalt Lake City
BOdygUardian MOnitoriNg for ReCurrencE of AF—Salt Lake City
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)N/ASalt Lake City
Cardiac Sarcoidosis Randomized TrialPhase 3Salt Lake City
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Phase 3Salt Lake City
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorPhase 4Salt Lake City
Comparing the Safety and Efficacy of Apixaban and RivaroxabanPhase 4Salt Lake City
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/ASalt Lake City
Cord Clamping Among Neonates With Congenital Heart DiseaseN/ASalt Lake City
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation—Salt Lake City
Dynamic Critical Congenital Heart Screening With Addition of Perfusion MeasurementsN/ASalt Lake City
EFS of the DUO System for Tricuspid RegurgitationN/ASalt Lake City
FORWARD CAD IDE StudyN/ASalt Lake City
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3Salt Lake City
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/ASalt Lake City
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device ImplantationN/ASalt Lake City
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future—Salt Lake City
Hydrogen's Feasibility and Safety as a Therapy in ECPRPhase 1Salt Lake City
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryN/ASalt Lake City
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart FailureN/ASalt Lake City
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Salt Lake City
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ASalt Lake City
LVAD Conditioning for Cardiac RecoveryN/ASalt Lake City
Left vs Left Randomized Clinical TrialN/ASalt Lake City
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)—Salt Lake City
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Salt Lake City
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/ASalt Lake City
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Salt Lake City
Physiology of Unloading VA ECMO TrialPhase 2Salt Lake City
Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)N/ASalt Lake City
Product Surveillance Registry—Salt Lake City
Randomized Trial of SGLT2i in Heart Transplant RecipientsPhase 4Salt Lake City
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Salt Lake City
RiLuzole to Reduce Atrial FIb Study Using Holter MonitoringPhase 2Salt Lake City
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VTN/ASalt Lake City
Simulation Trial of Telemedical Support for ParamedicsN/ASalt Lake City
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial HypercholesterolemiaPhase 3Salt Lake City
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial HypercholesterolemiaPhase 3Salt Lake City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Salt Lake City
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyPhase 3Salt Lake City
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/ASalt Lake City
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States StudyN/ASalt Lake City
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Salt Lake City
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPhase 3Salt Lake City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/ASalt Lake City
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/AWest Valley City

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.